used. Clinical isolates were obtained from several in Most of the strains were stab-cu stored at room temperature with tight stoppers. Strains diphtheriae and Brucella were cultured on heart fusio stored at room temperature.
Neisseria was cultured o egg yolk medium u incubator hili at 36°C. Hemophilus strains were stored after lyopzation.
The strains used in the experimental infections were as follows: 6 strains of S. aureus, 2 strains of E. S. pyogenes, i strain of S. pneumoniae, 3 strains of coli, 2 strains of K. pneumoniae and 3 strains of P. mirabilis. The strains were passed through anim several times before use for the selection of viruals lent cells and adaptation.
The strains were then suspended in broth containing 10 % glycerol and rulence stored in a deep freezer at -70°C to maintain vi. Each strain was streaked and cultured on nutrient agar plates or those containing 5 % horse blood immediately before use and normal colonies Sodium (6R, 7R)-8-oxo-7-[2(1H-tetrazol-l-yl) acetamido]-3-[ (1,3,4-thiadiazoi-2-ylthio) methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C13H11N8O4S3Na (M.W. 462.47) ltured in nutrient agar (0.5 % agar) medium, and of streptococci, pneumococci, Corynebacterium n agar slants containing 10% horse serum, and n lk me i m and stored in an in formed were used for challenge.
Determination of in vitro antibacterial activity.
In vitro antibacterial activities of ceftezole and related antibiotics were determined by the agarplate dilution method. Unless otherwise specified, an overnight culture (108~109 viable cells/ml) of each test strain in Trypticase soy broth (BBL, abbreviated as TSB) was diluted 100-fold (106-107 viable cells/ml). One loopful of this culture was streaked on each of several heart infusion (Eiken, abbreviated as HI) agar plates containing twofold serially graded concentrations of each antibiotic. The agar plates were cultured at 37°C for 18 hours, and the MIC value (µg/ml) was determined. For S. pneumoniae, S. pyogenes, C. diphtheriae and B. suis, TSB containing 10 % horse serum was used as the preculture medium and HI agar containing 10% defibrinated horse blood as the test medium for the determination of the MIC value. N. gonorrhoeae and N. meningitidis were cultured in GC agar containing 2°% hemoglobin using a 5%-CO2 incubator. For H. influenzae, chocolate agar containing 10% horse blood was used. 4 . Influence of various factors on antibacterial activity. The changes in MIC values of ceftezole and of cefazolin in response to various inoculum sizes, addition of human serum, different kinds of test media and pH values of a test medium were compared. As test strains, S. aureus 209P and E. coli NIHJ were used. The MIC value was determined by the twofold serial dilution liquid method in HI broth as the basal medium. Influence of serum on the MIC value was determined in HI broth supplemented with human serum, inactivated by heating at 60°C for 20 minutes at concentrations of 20, 30 or 40 %. To determine the influence of inoculum size, an overnight culture of each test strain in TSB was diluted 10-fold serially (103---103 viable cells/ml) and a one-tenth volume of each dilution was inoculated and cultured in each of a series of HI broth containing graded concentrations of each antibiotic. To examine the influence of test media, nutrient broth (Eiken), HI broth (Eiken), brain-heart infusion broth (Eiken) and TSB (Eiken) were chosen. In examining the influence of the pH of the test medium, HI broth at pH values of 5, 6, 7, 8 and 9 was used.
5. Estimation of bactericidal activity. S. aureus 209P and E. coli NIHJ were used as the test strains. After subculturing twice in HI broth, one volume of each was inoculated into nine volumes of the same medium and then incubated at 37°C for 2 hours with shaking. The culture was used as the inoculum at the logarithmic phase of growth.
Tubes of HI broth containing 1/2, 1, 2 or 4 times the MIC value of ceftezole or cefazolin were inoculated with the culture described above to give 106 viable cells/ml. These were incubated at 37'C with shaking, and sampled for determination of the numbers of viable cells by the agar plate method after 1, 3, 5, 8, 12 and 24 hours.
6. Morphological changes of bacterial cells. A logarithmic phase culture of E. coli NIHJ was prepared in a similar manner as described above. HI broth containing graded concentrations of ceftezole or the related antibiotic was inoculated with the culture to give 106 viable cells/ml and incubated at 37-C. Two or 3 hours after onset of growth, smear preparations of each culture were made; the morphological change of bacterial cells was observed microscopically after single staining. The remainders were submitted to further cultivation to calculate the MIC of each antibiotic.
7. In vitro development of resistance. S. aureus 209P and E. coli NIHJ were serially subcultured 16 times every day in nutrient broth (Eiken) containing increasing concentrations of ceftezole or a related antibiotic; each was inoculated at 37'C for 20 hours. The inoculation at each transfer was made from the most turbid culture.
8. Microbiological assay method for antibiotics. Concentrations of antibiotics were determined by the agar-plate diffusion method using paperdiscs. A 100-ml portion of melted nutrient agar was mixed with 0.1 ml of a spore suspension (10'' spores/ml) of Bacillus subtilis ATCC 6633. Five milliliter portions of the mixture were poured in Petri dishes and solidified to make agar plates. Paper-discs (Toyo Roshi Co., diameter: 8 mm, "thick" type) were dipped in the standard or a test solution. After the excess solution had been removed, the discs were placed on the agar plates. The diameters of inhibitory zones were measured after incubation at 37'C for 20 hours and the amounts of drugs in the test samples were calculated from the standard curves.
9. Stabilities in liquid media and tissue homogenates. Ceftezole and related antibiotics were dissolved individually in nutrient broth (Eiken, pH 7.0) to give concentrations of 10 µg/ml, which were kept at 5°C, 27°C and 37°C for 3 days. The residual activity in the medium was determined at one-day intervals by the paper-disc method.
To estimate the stability in tissue homogenates, male rats (S.D. strain, weighing about 150 g) were sacrificed by cervical dislocation and the blood, lungs, liver, spleen, kidneys and heart were removed. Serum was then separated from the blood and a 20% homogenate of each organ was prepared in 1/15 mt phosphate buffered saline (pH 7.0). After 1 ml of a solution of 200 hg/ml of ceftezole or a related antibiotic was mixed with the homogenate or serum; the mixture was incubated at 37°C for 30 or 90 minutes. After incubation, 2 ml of 99%ethanol was added to the reaction mixture to stop the enzymic activity, and the residual antibacterial activity in the mixture was determined by the paperdisc method.
10. Determination of binding rate to serum protein.
The binding rates of ceftezole and related antibiotics to human, rat, mouse, rabbit and dog serum protein were determined by the equilibrium dialysis method. After one volume of each antibiotic solution (250, 500, 1,000 or 2,000 /cg/ml) was added to nine volumes of serum, the mixture was incubated at 37''C for 60 minutes. Four ml of the resulting mixture were then put into a cellophane tube (,Visking, diameter: 18 mm) and dialyzed against 20 ml of 1/15 mt phosphate buffer (pH 7.4) at 4°C for 24 hours. The concentrations of antibiotics in the internal solution of the dialyzing tube were determined by the paper-disc method, and the binding rate to serum protein was calculated by the following formula:
Total amounts added-(external solution conc. Y Total vol.) Bi nding rate x 100 T otal amounts added 11. Experimental infections (intraperitoneal injection). Male mice, ddY strain, weighing 22-25 g, were used; each experimental group consisted of seven animals. Each challenge strain was cultured at 37°C for 20 hours in HI broth containing 0.5% yeast extract. After appropriate dilution with 3% mucin (Wako Junyaku Co., Mucin gastric, W-1701) or VOL. XXIX NO. 10 THE JOURNAL OF ANTIBIOTICS nutrient broth for S. pneumoniae, 0.4 ml doses of each diluted culture were inoculated intraperitoneally into mice. Ceftezole and other antibiotics were diluted twofold serially with sterilized physiological saline and each diluted solution was administered once subcutaneously into mice 1 hour after the challenge, or 3 times at 1-hour intervals from 1 hour after the challenge. The survival ratio of each experimental group was determined; the median effective dose (ED50) was calculated by the method of BEHRENS-KARBER. Virulence of challenge strains (LD50) was estimated by the death rate of the infected mice. Each challenge strain prepared as described above was diluted 10-fold serially with 3 % mucin or nutrient broth, and the diluted suspension was inoculated intraperitoneally into a group of 7 mice. The animals were observed for 7-10 days for the death rate and LD50values were calculated by the method of BEHRENS-KARBER.
Experimental infections (subcutaneous injection).
Male mice, ddY strain, weighing 2225 g, were used; each experimental group consisted of 5 mice. For the challenge, 6 strains of S. aureus were used. The experiments were carried out similarly as those described by TADOKORO3), and OSONo et al.°' Challenge strains were cultured on nutrient agar (Eiken) plates at 37°C for 24 hours. The bacterial cells were suspended in sterilized physiological saline to give a concentration of 109/ml, 0.1 ml of which was inoculated subcutaneously into the back of each mouse. Each antibiotic was administered twice subcutaneously in the infected mice 1and 2 hours after the challenge. Forty-eight hours after the challenge, the skin of each animal at the inoculation site was excised and the diameters of abscesses formed were measured from the visceral side. Then the doseresponse curves were drawn through the plots of the dose of each drug versus the mean diameter of the abscesses.
MIC for each challenge strain was determined by inoculating one loopful each of bacterial suspensions of 108/ml (without dilution) and of 108/ml (100-fold dilution). Results 
Antimicrobial Spectrum
The antimicrobial spectra of ceftezole and related antibiotics are summarized in Table 1 . Ceftezole was highly active against a wide range of both gram-positive and gram-negative bacteria, with the exception of P. aeruginosa, S. marcescens, P. vulgaris and P. morganii. Its antimicrobial spectrum was very similar to that of cefazolin.
Susceptibilities of Clinical Isolates
MIC values of ceftezole and related antibiotics for clinical isolates of several species is shown in Table 2 . Susceptibilities of 48 clinical isolates of S. aureus to ceftezole showed a peak at 0.20 pg/ml and no resistant strain with an MIC of 3.13 pg/ml or above was observed. The activity of ceftezole was slightly higher than those of cefazolin and cephalothin, and lower than that of cephaloridine.
Ceftezole also showed high activity against strains resistant to benzylpenicillin. Distribution of MIC values of ceftezole against 51 strains of E. coli and 46 strains of Klebsiella spp. showed peaks at 0.78 and 1.56 pg/mI, respectively. The growth of most strains was inhibited at 3.13 pg/ml or below, and no strain resistant to 100 ,ug/ml or above was observed. The activity of ceftezole was nearly the same as that of cefazolin and higher than those of cephaloridine and cephalothin.
The distribution of MIC values of ceftezole against 92 strains of P. mirabilis peaked at 3.13 ,ug/ml, and only four strains were resistant with MIC values of 50 jug/ml or above. The activity of ceftezole was apparently higher than that of cephaloridine and equal to or slightly higher than those of cefazolin and cephalothin.
There were some strains resistant to cephaloridine at 100 ug/ml or above among the clinical iso- Medium: Heart infusion agar Inoculum size: I loopfui of 106 cells/nil *: blood agar (10% horse blood) *: GC agar containing 2% hemoglobin ***: chocolate agar (10% horse blood) Drugs: CTZ (ceftezole), CEZ (cefazolin), CER (cephaloridine) , CET (cephalothin).
lates of P. mirabilis.
These strains were highly resistant to ampicillin with MIC values of 200 tg/ml or above. However, these strains were susceptible to ceftezole and cefazolin (Figs. 2 and 3 ).
Nearly all 24 isolates of P. vulgaris were highly resistant to ceftezole, cefazolin , cephaloridine and cephalothin with MIC values higher than I00tg/ml.
A total of 34 strains of P. morganii, P . rettgeri and XXIX NO. Inoculum size: I loopful of 106 cells/ml *: Benzylpenicillin , unit/ml **: Ampicillin P. incoustaus, and 48 strains of Citrobacter spp. showed widely different susceptibilities to ceftezole.
Influences of Various Experimental Conditions on Activity In Vitro
Influences of inoculum sizes, pH values of the test medium, presence of human serum and test media on the activitie's of ceftezole and cefazolin in vitro were examined with S. aureus 209P and E. coli NIHJ as test organisms.
The results are shown in Table 3 .
With different inoculum sizes of S. aureus 209P, MIC values of ceftezole and cefazolin hardly fluctuated.
With a large inoculum size of E. coli NIHJ, the MIC value of ceftezole tended to become higher than that of cefazolin.
Both ceftezole and cefazolin were more active at acidic pH than at alkaline pH.
Addition of human serum even at 40% to the test medium did not change the MIC value of ceftezole against S. aureus 209P, whereas it tended to increase the MIC value of cefazolin.
The MIC values of ceftezole fluctuated slightly in different test media and this tendency was also observed with cefazolin.
Bactericidal Activity
The bactericidal activity of ceftezole was compared with that of cefazolin with S. aureus 209P As shown in Fig. 8 , the stability of ceftezole in nutrient broth was found to be substantially -equal to that of cefazolin and higher than those c of cephaloridine and cephalothin. About 80% C of the initial activity was maintained after inc cubating ceftezole at 37°C for 3 days. C
The results of stability tests of ceftezole and C related antibiotics in rat serum and tissue homogenates are shown in Fig. 9 . Little or no decrease in activity was observed after incubating ceftezole, cefazolin or cephaloridine in rat serum or in or heart at 37°C for 90 minutes. In contrast, the act rat tissue homogenate. Table   There were considerable differences in binding rates to serum protein of different animal species. t,t 50 /tg/ml of ceftezole, the binding rates to human serum and the sera of various animals were as ollows: human 69 rat 70°0, mouse 53 ° rabbit 83 and dog 25' .,'. From these results, the binding ate of ceftezole was similar or slightly higher than that of cephalothin and higher than that of cephaloidine. However, the binding rate of ceftezole was apparently lower than that of cefazolin. In dog serum, he binding rate of all antibiotics was remarkably low and almost no difference was observed among he drugs. One volume of an antibiotic solution was added to 9 volumes of serum. After incubation at 37°C for 60 minutes, the mixture was dialyzed against 1/15 M phosphate buffer (pH 7.4) at 4°C for 24 hours. the infections caused by the gram-negative rods. Ceftezole was somewhat less efficacious than either cefazolin or cephaloridine by single administration, but was similar in efficacy to the other two antibiotics when administered in three doses.
In addition, cephaloridine had poor efficacy against the infection with P. mirabilis JU-453, a highly resistant strain with a MIC of 200 jug/ml, although both ceftezole and cefazolin exhibited good efficacy.
Suppressive Effects against Experimental Abscess Formation
in Mice Challenged Subcutaneously Six clinical isolates of S. aureus with the ability to form subcutaneous abscesses were used for challenge. Ceftezole given in two divided doses was compared with cefazolin, cephalothin and ampicillin for suppressive activity. Abscess formation was induced by subcutaneous inoculation. The results are shown in Fig. 10 .
Although the effects of each drug varied slightly depending on challenge strain, ceftezole and cefazolin appeared to be more effective than cephalothin.
Ampicillin was highly effective against infections with susceptible strains (215 and JU-39) but demonstrated little or no efficacy against infections either with strains of low resistance at large inoculum sizes (JU-48 and JU-38) or with highly resistant strains (JU-5 and JU-33).
VOL. The antibacterial spectrum of ceftezole including its activity in vitro against clinical isolates was similar to that of cefazolin. The activity of ceftezole against gram-positive bacteria was somewhat lower than that of cephaloridine. However, against gram-negative rods, especially E. co/i, Klebsiella spp. and P. mirabilis, the activity of ceftezole was higher than those of cephaloridine and cephalothin.
It was found that clinical isolates of P. mirahilis highly resistant to ampicillin were also resistant to cephaloridine. However, these strains were susceptible to both ceftezole and cefazolin. The resistance of these isolates was derived from R-plasmids (unpublished data). Therefore, it is indicated that Rplasmid-bearing strains of gram-negative rods have not acquired resistance to ceftezole as yet.
NEHASHI et al.5 studied the stability of ceftezole against various ;I-lactamases and found that ceftezole was highly stable against penicillinase-type /3-lactamase of S. aureus, and that it was also only minimally hydrolyzed by penicillinase-type /3-lactamase which was mediated by conjugative R-plasmids of gram-negative rods. However, they found that ceftezole and other cephalosporin C antibiotics were easily hydrolyzed by the chromosomally originated cephalosporinase type /3-lactamase of Enterobacter cloacae, a strain highly resistant to ceftezole.
The bactericidal activity of ceftezole was found to be nearly the same as that of cefazolin. Both ceftezole and cefazolin were highly stable in test media and in rat tissue homogenates.
The binding of cefazolin to human serum protein was considerably higher than that of cephaloridine. However, binding of ceftezole was lower than that of cefazolin, and equivalent to that of cephalothin.
In experimental intraperitoneal infections in mice with gram-positive bacteria or gram-negative rods, the protective effects of ceftezole by single administration were slightly lower than those of cefazolin, but ceftezole was as effective as cefazolin when administered in three doses. As will be reported in a subsequent paper," the blood levels of ceftezole were lower than those obtained with cefazolin, and the retention time of the former was also slightly shorter than that of the latter. Therefore, maximum efficacy may not be obtained by a single administration of ceftezole in those experiments where efficacy is determined by septic death; it is believed that the activity in vitro would be reflected in vivo if repeated administrations of the antibiotic are made.
The suppression by ceftezole of subcutaneous abscess formation by S. aureus was similar to that of cefazolin. Clinical effectiveness of ceftezole against local infections can be expected as the antibiotic is distributed uniformly throughout the various tissue of animals."
